Latest filing published 28 Mar 2018 for Eloxx Pharmaceuticals, Inc., €15k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Zafrira Avnur: trading record in brief
Zafrira Avnur appears in our data through filings on Eloxx Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 21 March 2018 to 26 March 2018, the count stands at 2 filings.
The open-market record is one-sided, with 2 purchases worth €17k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The latest filing, published on 28 March 2018, reports an open-market purchase of €15k in Eloxx Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Zafrira Avnur
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$9.4990.3% of flowCommon StockSEC:0001209191-18-021928:0Canonical exit: 24 Jun 2018 (T+90)
- 263 shares@ US$7.609.7% of flowCommon StockSEC:0001209191-18-021336:0Canonical exit: 19 Jun 2018 (T+90)
2 of 2 declarations
